Piotr Gluszko | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Best Researcher Award

Piotr Gluszko
National Institute of Geriatrics, Poland

Piotr Gluszko
Affiliation National Institute of Geriatrics
Country Poland
Scopus ID 6603791530
Documents 105
Citations 2,530
h-index 22
Subject Area Medicine and Dentistry
Event Global Scholar Awards
ORCID 0000-0001-5717-4472

The Best Researcher Award recognizes distinguished scholarly achievement, sustained scientific contributions, and measurable impact within a specialized academic discipline. Piotr Gluszko has established a notable research profile in medicine and dentistry through extensive publication activity, citation influence, and engagement in clinical and translational research initiatives. His academic record reflects continued contributions to evidence-based healthcare and rheumatology-related investigations, supporting advancements in patient care and scientific understanding.[1]

Abstract

Piotr Gluszko is a medical researcher associated with the National Institute of Geriatrics in Poland whose scholarly work has contributed to clinical medicine, rheumatology, musculoskeletal disorders, and evidence-based healthcare.[3] His publication portfolio demonstrates sustained engagement in research addressing diagnosis, treatment outcomes, patient management, and healthcare quality. With more than one hundred indexed documents and significant citation performance, his work has supported scientific communication and clinical advancement. The combination of publication productivity, research visibility, and academic influence highlights a professional record aligned with the standards commonly recognized through international academic distinctions and researcher excellence awards.[1][2]

Keywords

  • Rheumatology
  • Geriatric Medicine
  • Clinical Research
  • Musculoskeletal Disorders
  • Healthcare Outcomes
  • Evidence-Based Medicine
  • Patient Care
  • Inflammatory Diseases
  • Medical Research
  • Dentistry
  • Scientific Publications
  • Academic Impact

Introduction

Piotr Gluszko has contributed to medical science through investigations focused on rheumatology, patient care, and clinical outcomes. His research activities emphasize evidence-based approaches that support improved healthcare delivery and scientific understanding. Through collaborative studies and scholarly dissemination, he has maintained a visible presence within the international medical research community.[1]

Research Profile

Affiliated with the National Institute of Geriatrics, Piotr Gluszko has developed a substantial publication record comprising indexed articles, reviews, and collaborative studies. His scholarly metrics, including citations and h-index performance, reflect sustained academic engagement and recognition within medicine and dentistry-related research disciplines.[1]

Research Contributions

His contributions include advancing knowledge in rheumatic diseases, clinical management strategies, healthcare assessment, and treatment evaluation. Research outputs have supported scientific discussions regarding disease mechanisms, therapeutic effectiveness, and patient-centered care while contributing to broader clinical practice and medical education initiatives.[2]

Publications

The researcher has produced more than one hundred indexed publications spanning clinical medicine and rheumatology. These works include original investigations, collaborative studies, reviews, and scholarly communications that contribute to scientific literature and provide evidence supporting healthcare decision-making and future research development.[1]

Research Impact

Citation performance exceeding two thousand references indicates meaningful scholarly visibility and academic utilization. The influence of his research extends across clinical practice, scientific communication, and healthcare investigations, demonstrating relevance to researchers, clinicians, and institutions engaged in evidence-based medicine.[4]

Award Suitability

The combination of publication productivity, citation influence, recognized expertise, and sustained research engagement supports consideration for the Best Researcher Award. His scholarly achievements align with evaluation criteria emphasizing research quality, scientific contribution, academic visibility, and measurable impact within medicine and dentistry.[1]

Conclusion

Piotr Gluszko’s academic record demonstrates sustained commitment to medical research, publication excellence, and scientific advancement. His contributions, supported by strong bibliometric indicators and international visibility, represent qualities commonly associated with distinguished scholarly recognition and researcher achievement awards.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Piotr Gluszko, Author ID 6603791530. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=6603791530

  2. Gluszko, P., et al. Clinical characteristics of Polish patients with ANCA-associated vasculitides-retrospective analysis of POLVAS registry.

    https://doi.org/10.1038/s41584-020-00526-0

  3. ORCID. (n.d.). Piotr Gluszko ORCID Record.

    https://orcid.org/0000-0001-5717-4472

  4. ResearchGate. (n.d.). ResearchGate profile of Piotr Gluszko.

    https://www.researchgate.net/profile/Piotr-Gluszko-2

Xiaoguang Huang | Pharmacology | Innovative Research Award

Published on by Global Scholar Awards

Innovative Research Award

Xiaoguang Huang
Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd, China

Xiaoguang Huang
Affiliation Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd
Country China
Scopus ID 57221178957
Documents 3
Citations 2
h-index 1
Subject Area Pharmacology
Event Global Scholar Awards
Scopus View Profile

Xiaoguang Huang is affiliated with Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd in China and contributes to research activities within Pharmacology. His academic profile demonstrates participation in scientific publications, citation visibility, and pharmaceutical research engagement. These scholarly activities support recognition within the Global Scholar Awards and reflect continued involvement in pharmacological and healthcare-related scientific advancement.[1]

Abstract

Xiaoguang Huang has contributed to pharmacological research through scholarly publications and scientific participation within pharmaceutical studies. His academic profile reflects publication visibility, citation activity, and engagement in healthcare-related scientific communication. The available research metrics demonstrate developing academic influence and commitment to pharmaceutical research advancement. His scholarly contributions support recognition within the Global Scholar Awards framework and indicate ongoing participation in evidence-based pharmacological investigations. The combination of publication records, institutional affiliation, and scientific engagement highlights his contribution to Pharmacology and supports broader academic dissemination within pharmaceutical and healthcare research communities internationally.[1]

Keywords

  • Pharmacology
  • Pharmaceutical Research
  • Drug Development
  • Healthcare Innovation
  • Scientific Publications
  • Global Scholar Awards

Introduction

Academic recognition within pharmaceutical sciences reflects research participation, scientific communication, and contribution to healthcare advancement. Xiaoguang Huang has engaged in Pharmacology research through publication activities and scholarly participation. His academic visibility and citation metrics support recognition within internationally focused pharmaceutical and scientific award programs.[1]

Research Profile

Xiaoguang Huang is affiliated with Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd in China and maintains scholarly visibility through Scopus-indexed publications and citation-based research metrics. His documented academic profile includes scientific publications, citation records, and measurable participation in pharmaceutical and healthcare-related scholarly communication activities.[1]

Research Contributions

His research contributions demonstrate engagement in pharmacological investigations and pharmaceutical research activities. Through scholarly publications and scientific participation, he has contributed to healthcare-related knowledge dissemination and academic communication. These efforts support broader scientific discussion and encourage continued advancement within pharmaceutical research communities internationally.[2]

Publications

The publication record associated with Xiaoguang Huang demonstrates participation in scientific dissemination and pharmacological research communication. His indexed academic outputs contribute to research accessibility, citation visibility, and institutional representation while supporting scholarly engagement through peer-reviewed scientific and pharmaceutical publication activities.[1]

Research Impact

Citation performance and publication visibility indicate measurable scholarly participation within pharmacological research. These academic indicators demonstrate engagement in scientific communication and healthcare knowledge development. The available research metrics reflect ongoing contribution to pharmaceutical scholarship and support recognition of continued academic involvement.[1]

Award Suitability

Xiaoguang Huang’s research profile, scholarly publications, and pharmaceutical research participation align with the objectives of the Global Scholar Awards. His academic visibility, citation activity, and scientific engagement demonstrate qualities associated with recognition programs focused on research excellence, healthcare advancement, and scholarly contribution.[3]

Conclusion

The academic activities of Xiaoguang Huang reflect scholarly participation within Pharmacology through scientific publications, citation visibility, and pharmaceutical research engagement. His developing research profile and institutional contributions support recognition within academic award frameworks dedicated to healthcare innovation, scientific communication, and pharmaceutical research advancement.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Xiaoguang Huang, Author ID 57221178957. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57221178957
  2. Global Scholar Awards. (n.d.). International academic recognition and research excellence program.
    Global Scholar Awards
  3. Huang, X., Zhang, A., Chen, D., Jia, Z., & Li, X. (2026). 4-Substituted 4-(1H-1,2,3-triazol-1-yl)piperidine: Novel C7 moieties of fluoroquinolones as antibacterial agents. SSRN Electronic Journal.
    https://pubmed.ncbi.nlm.nih.gov/20347299/

Marla Shapiro C.M. | Medicine and Dentistry | Research Excellence Award

Published on by Global Scholar Awards

Dr. Marla Shapiro C.M. | Medicine and Dentistry | Research Excellence Award

Professor | University of Toronto | Canada

Dr. Marla Shapiro is an Associate Professor at the University of Toronto, Canada, specializing in menopause research, vasomotor symptoms, and women’s midlife health. Her scholarship focuses on advancing evidence-based, non-hormonal and hormonal therapeutic strategies for managing moderate to severe menopausal symptoms. She has published 34 peer-reviewed articles, receiving 1,713 citations, with an h-index of 14, demonstrating consistent academic influence. Dr. Shapiro has played a key role in international phase 3 and 3b clinical trials, including responder and pooled analyses of fezolinetant, published in leading journals such as Maturitas and Menopause. Through collaborations with more than 180 international co-authors, her work has informed clinical decision-making, supported guideline development, and contributed meaningfully to improving quality of life and healthcare outcomes for menopausal women worldwide.

Citation Metrics (Scopus)

1713
1200
800
400
0

Citations

1,713

Documents

34

h-index

14

Citations

Documents

h-index

View Scopus Profile
 View ResearchGate Profile

Featured Publications

Ming-Yow Hung | Medicine and Dentistry | Research Excellence Award

Published on by Global Scholar Awards

Prof. Ming-Yow Hung | Medicine and Dentistry | Research Excellence Award

Professor | Shuang Ho Hospital, Taipei Medical University | Taiwan

Dr. Ming Yow Hung is a distinguished researcher at Taipei Medical University, Taiwan, specializing in cardiovascular biology, molecular cardiology, and stem cell research. His work focuses on understanding coronary artery disorders, including vasospasm, Kounis syndrome, and allergic myocardial infarction, through experimental, translational, and epigenetic approaches. He has authored numerous peer-reviewed publications, with significant citation impact reflecting his influence in cardiovascular and pharmaceutical research. Dr. Hung collaborates extensively with international teams, contributing to multidisciplinary studies that integrate molecular mechanisms, induced pluripotent stem cell models, and clinical insights. His research advances understanding of disease mechanisms and informs therapeutic strategies, with clear societal relevance in improving cardiovascular health, personalized medicine, and patient care, positioning him as a globally recognized and impactful scientist in cardiovascular research.

Citation Metrics (Scopus)

1,824
1,400
900
450
0

Citations

1,824

Documents

57

h-index

20

Citations

Documents

h-index

View Scopus Profile
 View ORCID Profile

Featured Publications

Xin Li | Sports Medicine | Best Researcher Award

Published on by Global Scholar Awards

Assoc. Prof. Dr. Xin Li | Sports Medicine | Best Researcher Award

Associate Professor| Tianjin Normal University | China

Dr. Xin Li is an accomplished scholar and educator specializing in clinical medicine and sports health sciences, currently serving as an Associate Professor at Tianjin Normal University since 2006. She obtained her Doctor of Medicine (MD) in Clinical Medicine from Tianjin Medical University in July 2006. Over nearly two decades of academic and research experience, Dr. Li has established herself as a leading expert at the intersection of clinical medicine, exercise science, and health management. Her teaching portfolio encompasses a range of courses in sports health, exercise rehabilitation, and health management, with a focus on integrating clinical case studies into theoretical instruction to enhance students’ practical competencies and professional insight. Dr. Li’s research primarily addresses exercise interventions for chronic diseases, sports injury prevention, and rehabilitation science, contributing to the growing evidence base linking physical activity with disease prevention and functional recovery. She has led and participated in numerous provincial and municipal research projects, achieving notable outcomes that have advanced the application of medical principles in sports health practice. To date, Dr. Li has published over ten academic papers in peer-reviewed core journals and international conferences, several of which have been widely cited and recognized within the academic community for their methodological rigor and clinical relevance. Her collaborative approach bridges disciplines such as physiology, public health, and kinesiology, fostering innovation and interdisciplinary integration in sports medicine research. Beyond academia, Dr. Li’s work holds significant societal impact, promoting the scientific development of exercise-based health strategies for chronic disease management and population well-being. Combining solid clinical expertise, pedagogical excellence, and a strong research record, Dr. Xin Li continues to contribute meaningfully to the advancement of sports health education and evidence-based medical practice in China and beyond.

Profile: Scopus 

Featured Publications

Li, X. (2025). The influence of initial and final character positional probabilities on the flexibility of position coding in two-character word identification. Acta Psychologica Sinica.

Dr. Xin Li’s work bridges clinical medicine and sports science, advancing evidence-based approaches to exercise intervention, chronic disease prevention, and rehabilitation. Her research and teaching contribute to improving public health outcomes and enhancing human performance, promoting global innovation in integrated medical and sports health education.

Shaoqing Yu | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Prof. Dr. Shaoqing Yu | Medicine and Dentistry | Best Researcher Award

Directors of Department in Hospital| Tongji University | China

Dr. Shaoqing Yu, PhD, is the Director of the Departments of Otorhinolaryngology–Head and Neck Surgery and Allergy at Tongji Hospital, School of Medicine, Tongji University, Shanghai, China. An accomplished clinician-scientist, Dr. Yu specializes in allergy, immunology, and otorhinolaryngology, with a research focus on the mechanisms and clinical management of allergic rhinitis and upper airway inflammation. He has led or participated in more than 20 major research projects, including those funded by the National Natural Science Foundation of China, and has published over 70 peer-reviewed papers in high-impact international journals such as JAMA, Allergy, Clinical and Experimental Allergy, and Clinical Reviews in Allergy & Immunology. His work has substantially advanced understanding of immune regulation and translational therapies in allergic diseases. Dr. Yu is an active member of the European Academy of Allergy and Clinical Immunology (EAACI) and the Chinese Society of Otolaryngology in Traditional Chinese and Western Medicine, fostering global and interdisciplinary collaborations. His achievements have been recognized through numerous awards, including the Third Prize of the Shanghai Medical Technology Award, the Third Prize of the Military Medical Achievement Award, and the Tongji University Taihe Medical Education Award. With over 20 patents to his name and selection for the prestigious Shanghai Oriental Talent Plan, Dr. Yu continues to contribute significantly to medical innovation, education, and the improvement of public health outcomes in China and internationally.

Profiles: Scopus | ORCID 

Featured Publications

Yu, S., et al. (2025). An anti-TSLP monoclonal antibody for uncontrolled CRSwNP: The DUBHE randomized clinical trial. Nature Communications.

Yu, S., et al. (2025). Efficacy and safety of intranasal corticosteroids combined with mucoactive drugs for chronic rhinosinusitis. International Immunopharmacology.

Yu, S., et al. (2025). Xylulose 5-phosphate fosters sustained antitumor activity of progenitor-like exhausted SLC35E2⁺ CD8⁺ T effector cells. Cell Metabolism.

Yu, S., et al. (2025). Automatic segmentation of clear cell renal cell carcinoma based on deep learning and a preliminary exploration of the tumor microenvironment. Translational Andrology and Urology.

Yu, S., et al. (2025). Long-term administration of hydrogen-rich water enhances quality of life in diabetic rats and reduces renal neoplasm incidence through modulation of inflammatory and metabolic pathways. Translational Andrology and Urology.

Dr. Shaoqing Yu’s pioneering research in allergy and immunology has advanced understanding of airway inflammatory diseases and driven the development of innovative diagnostic and therapeutic strategies. His work bridges basic science and clinical application, improving patient outcomes and shaping global standards in allergic disease management.

Gwendolyn Quinn | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Prof. Dr. Gwendolyn Quinn | Medicine and Dentistry | Best Researcher Award

Professor| New York University| United States

Dr. Gwendolyn P. Quinn is an internationally recognized behavioral scientist and bioethicist whose research focuses on patient–provider communication, reproductive ethics, and quality of life among cancer patients, particularly adolescents, young adults, and sexual and gender minority populations. She is Professor and Vice Chair of Research in the Departments of Obstetrics and Gynecology and Population Health at the New York University Grossman School of Medicine, where she also holds the Livia Wan Endowed Chair and is a member of the Division of Medical Ethics and the Perlmutter Cancer Center. Dr. Quinn’s work integrates behavioral science, ethics, and public health to enhance communication about reproductive health, genetics, and fertility preservation for individuals undergoing gonadotoxic treatment. She directs the NCI-funded ENRICH/ECHO training program, which improves oncology providers’ communication skills in reproductive and genetic health, and has contributed to national and international guidelines for ASCO, ASRM, and the PANCARE Life consortium. With more than 450 peer-reviewed publications—approximately 300 focused on reproductive health and bioethics—Dr. Quinn has significantly influenced research and practice in oncofertility, ethics, and cancer survivorship. She has served on the Board of Scientific Counselors for the National Institute of Environmental Health Sciences and holds fellowships in the American Association for Cancer Education and the New York Academy of Medicine. Her numerous honors, including the American Psychosocial Oncology Society’s Outstanding Education and Training Award, reflect her sustained leadership and impact on advancing equitable reproductive health care, ethical medical practice, and the education of future generations of researchers and clinicians worldwide.

Profiles: Google Scholar |Scopus | ORCID

Featured Publications

Loren, A. W., Mangu, P. B., Beck, L. N., Brennan, L., Magdalinski, A. J., Partridge, A. H., … & Quinn, G. P. (2013). Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. Journal of Clinical Oncology, 31(19), 2500–2510. Cited by: 1,901

Oktay, K., Harvey, B. E., Partridge, A. H., Quinn, G. P., Reinecke, J., Taylor, H. S., … & Loren, A. W. (2018). Fertility preservation in patients with cancer: ASCO clinical practice guideline update. Journal of Clinical Oncology, 36(19), 1994–2001. Cited by: 1,663

Quinn, G. P., Sanchez, J. A., Sutton, S. K., Vadaparampil, S. T., Nguyen, G. T., Green, B. L., … & Schabath, M. B. (2015). Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populations. CA: A Cancer Journal for Clinicians, 65(5), 384–400. Cited by: 551

Quinn, G. P., Vadaparampil, S. T., Lee, J. H., Jacobsen, P. B., Bepler, G., Lancaster, J., & Keefe, D. L. (2009). Physician referral for fertility preservation in oncology patients: A national study of practice behaviors. Journal of Clinical Oncology, 27(35), 5952–5957. Cited by: 490

Nahata, L., Tishelman, A. C., Caltabellotta, N. M., & Quinn, G. P. (2017). Low fertility preservation utilization among transgender youth. Journal of Adolescent Health, 61(1), 40–44. Cited by: 345

 

Dr. Gwendolyn P. Quinn’s pioneering work in reproductive ethics, patient–provider communication, and oncofertility has transformed clinical practice and education worldwide, advancing equitable reproductive health care for cancer patients and sexual and gender minorities. Her research and training initiatives have shaped global guidelines and strengthened ethical, compassionate communication in medicine.

Nermin Mutlu Bilgic | Gastroenterology | Best Researcher Award

Published on by Global Scholar Awards

Dr. Nermin Mutlu Bilgic | Gastroenterology | Best Researcher Award

Specialist | University of health sciences | Turkey

Dr. Nermin Mutlu Bilgic is a Gastroenterology Specialist at the University of Health Sciences Ümraniye Training and Research Hospital in Istanbul, Türkiye. She earned her Doctor of Medicine degree from Istanbul University Cerrahpaşa Faculty of Medicine in 2004, completed her residency in Internal Medicine at Maltepe University between 2007 and 2012, and obtained her subspecialty in Gastroenterology at Ümraniye Training and Research Hospital from 2015 to 2019. With over fifteen years of academic and clinical experience, Dr. Bilgiç specializes in hepatology, metabolic liver diseases, and inflammatory gastrointestinal disorders. She has served as Principal Investigator for international multicenter clinical trials evaluating the efficacy and safety of Saroglitazar Magnesium in patients with Primary Biliary Cholangitis and Nonalcoholic Steatohepatitis, reflecting her active contribution to global research in liver diseases. She has received certified training in Good Clinical Practice (GCP) from Roche/Genentech and the Global Health Training Centre, ensuring compliance with international ethical and regulatory standards. Dr. Bilgiç has authored and co-authored peer-reviewed publications and presented her work at several national and international gastroenterology and internal medicine conferences. Her professional focus integrates patient-centered clinical care with translational research aimed at improving therapeutic outcomes and understanding the mechanisms of chronic liver disease. She is also actively engaged in mentoring residents and fellows, contributing to medical education and the advancement of clinical research culture within her institution. Through her leadership in clinical trials, scientific collaborations, and commitment to ethical medical practice, Dr. Nermin Mutlu Bilgiç continues to make a meaningful impact on the advancement of gastroenterology and hepatology in both national and international contexts.

Profiles: Google Scholar | ORCID

Featured Publications

Kul, S., Caliskan, Z., Guvenc, T. S., Celik, F. B., Sarmis, A., Atici, A., Konal, O., Akıl, M., & Bilgiç, N. M. (2023). Gut microbiota-derived metabolite trimethylamine N-oxide and biomarkers of inflammation are linked to endothelial and coronary microvascular function in patients with …. Microvascular Research, 146, 104458 Cited by 31

Sayar, S., Aykut, H., Kaya, Ö., Kürbüz, K., Ak, Ç., Gökçen, P., Bilgiç, N. M., Adalı, G., & others. (2021). Bone mineral density screening and the frequency of osteopenia/osteoporosis in Turkish adult patients with celiac disease. The Turkish Journal of Gastroenterology, 32(7), 600–606 Cited by 13

Sayar, S., Kürbüz, K., Kahraman, R., Öztürk, O., Çalışkan, Z., Doğanay, H. L., Bilgiç, N. M., & others. (2020). Risk of hepatitis B reactivation during anti-TNF therapy: Evaluation of patients with past hepatitis B infection. The Turkish Journal of Gastroenterology, 31(7), 522–528 Cited by 13

Ozdil, K., Ozturk, O., Çalık, E. S., Akbas, E. S., Kanat, E., Caliskan, Z., Demirdag, H., Bilgiç, N. M., & others. (2016). Relationship between size of varices and platelet count/spleen size ratio in cirrhotic patients. Northern Clinics of Istanbul, 3(1), 46–50 Cited by 11

Adali, G., Bilgiç, N. M., Kalaman, A. E., Ozturk, O., & Ozdil, K. (2023). Prevalence and predictors of metabolic-associated fatty liver disease in liver transplant recipients: A cross-sectional prospective study. Hepatology Forum, 4(3), 129–135 Cited by 8

 

Dr. Nermin Mutlu Bilgic work advances the understanding and management of chronic liver and metabolic diseases through evidence-based clinical research and international collaboration. Her contributions to hepatology and gastroenterology foster improved patient outcomes, support ethical research practices, and drive innovation in global liver health.

Luigi Montano | Medicine and Dentistry | Outstanding Scientist Award

Published on by Global Scholar Awards

Dr. Luigi Montano | Medicine and Dentistry | Outstanding Scientist Award

Medico at Local Health Authority Salerno, Italy

Dr. Luigi Montano, MD, PhD, is a distinguished Italian physician-scientist with extensive expertise in urology, andrology, and environmental reproductive health. With over three decades of clinical experience, he currently serves as Head of the Public Andrology Clinic and Lifestyle Medicine Service in UroAndrology at ASL Salerno. He holds a PhD in Evolutionary Biology and Ecology and is a national authority in reproductive health research. Dr. Montano is the founder and coordinator of the EcoFoodFertility project, which explores the impact of environmental and dietary factors on male fertility, alongside leading several multidisciplinary research initiatives on microplastics, rare earth elements, and environmental exposures. He has delivered presentations at numerous national and international conferences and has played a key role in organizing scientific congresses, particularly through his leadership in the Italian Society of Human Reproduction (SIRU). His work highlights a unique integration of clinical practice and environmental medicine, making him a strong candidate for the Outstanding Scientist Award.

Professional Profile 

Education🎓

Dr. Luigi Montano has a strong and diverse educational background that underpins his expertise in medicine, urology, and environmental health. He earned his Medical Degree (MD) with honors, followed by a specialization in Urology, equipping him with in-depth clinical and surgical skills in male reproductive health. Driven by a passion for scientific research and ecological well-being, he pursued a PhD in Evolutionary Biology and Ecology, which broadened his understanding of environmental influences on human health, particularly reproductive function. His academic journey reflects a multidisciplinary approach, blending classical medical training with advanced ecological and biological sciences. Throughout his education, Dr. Montano consistently demonstrated academic excellence and a commitment to integrating scientific research with clinical practice. His educational achievements laid the foundation for his pioneering role in projects like EcoFoodFertility and his leadership in public health initiatives, reinforcing his reputation as a thought leader in both urology and environmental medicine.

Professional Experience📝

Dr. Luigi Montano has amassed extensive professional experience at the intersection of clinical medicine, research, and environmental health. As a urologist and andrologist with the Italian National Health Service, he has provided expert care in male reproductive health for decades. Beyond his clinical role, Dr. Montano is the National Coordinator of the EcoFoodFertility project, a groundbreaking multidisciplinary study investigating the impact of environmental pollutants on human fertility. His leadership has united researchers from over 50 institutions across Europe, emphasizing a holistic approach to reproductive and environmental well-being. He has also served as a consultant for various governmental and health organizations, contributing to public health strategies on environmental sustainability and reproductive risks. Dr. Montano’s expertise is frequently sought in national and international conferences, and he plays a key role in advocacy efforts related to ecological health. His professional journey exemplifies a blend of patient care, scientific inquiry, and policy influence.

Research Interest🔎

Dr. Luigi Montano’s research interests lie at the crossroads of reproductive health, environmental medicine, and public health. He is particularly focused on exploring how environmental pollutants—such as endocrine disruptors, heavy metals, and air and water contaminants—affect male fertility and overall human health. As the founder and coordinator of the EcoFoodFertility project, Dr. Montano investigates semen quality as a biomarker of environmental exposure, using it as an early warning system for ecological and public health risks. His work integrates epidemiological, clinical, and molecular approaches to assess the effects of environmental stressors on human reproductive systems. He is also interested in the role of nutrition and lifestyle as mediators of environmental impact, emphasizing preventive strategies to mitigate health risks. Through his multidisciplinary collaborations, Dr. Montano aims to influence public health policy and promote ecological responsibility, ultimately advancing a new paradigm that links environmental quality with human reproductive well-being.

Award and Honor🏆

Dr. Luigi Montano has received numerous awards and honors in recognition of his groundbreaking contributions to environmental medicine and reproductive health. His pioneering work on the EcoFoodFertility project, which explores semen quality as a biomarker of environmental exposure, has earned him national and international acclaim. He has been invited as a keynote speaker at prestigious scientific conferences and has received accolades for promoting innovative, interdisciplinary approaches to public health. Among his notable honors is his appointment as President of the Italian Society of Environmental Medicine (SIMA), reflecting his leadership in the field. Dr. Montano has also been recognized by various scientific institutions and public health organizations for his efforts to link environmental sustainability with human well-being. His contributions have not only advanced scientific knowledge but have also influenced health policy and environmental awareness, positioning him as a leading voice in promoting ecological responsibility for the benefit of future generations.

Research Skill🔬

Dr. Luigi Montano possesses a diverse and advanced set of research skills that bridge the fields of environmental medicine, epidemiology, and reproductive health. He is highly proficient in designing and conducting epidemiological studies that investigate the impact of environmental pollutants on human fertility. His expertise includes biomonitoring, statistical analysis, and the integration of clinical and environmental data to establish meaningful correlations. Dr. Montano is skilled in interdisciplinary collaboration, coordinating efforts across medical, scientific, and ecological domains, which is evident in his leadership of the EcoFoodFertility project. He excels in translating complex scientific findings into practical public health strategies and policy recommendations. Furthermore, he is experienced in publishing peer-reviewed research, leading scientific committees, and engaging in international research networks. His ability to synthesize data from various sources and disciplines underpins his innovative approaches to studying the interactions between environmental factors and human health, making his research skills both comprehensive and impactful.

Conclusion💡

Dr. Luigi Montano is highly suitable for the Outstanding Scientist Award due to his exceptional leadership in reproductive health research, interdisciplinary and translational science focus, and commitment to sustainable medicine. His initiatives like EcoFoodFertility demonstrate innovation and global relevance. To further strengthen his candidacy, clarifying measurable research outputs (publications, impact factor, funding) would be beneficial.

Publications Top Noted✍️

  1. Pironti C, Ricciardi M, Motta O, Miele Y, Proto A, Montano L.
    Microplastics in the environment: intake through the food web, human exposure and toxicological effects

    • Journal: Toxics

    • Year: 2021

    • Citations: 274

  2. Pironti C, Ricciardi M, Proto A, Bianco PM, Montano L, Motta O.
    Endocrine-disrupting compounds: An overview on their occurrence in the aquatic environment and human exposure

    • Journal: Water

    • Year: 2021

    • Citations: 218

  3. Montano L, Pironti C, Pinto G, Ricciardi M, Buono A, Brogna C, Venier M, et al.
    Polychlorinated biphenyls (PCBs) in the environment: occupational and exposure events, effects on human health and fertility

    • Journal: Toxics

    • Year: 2022

    • Citations: 193

  4. Pironti C, Notarstefano V, Ricciardi M, Motta O, Giorgini E, Montano L.
    First evidence of microplastics in human urine, a preliminary study of intake in the human body

    • Journal: Toxics

    • Year: 2022

    • Citations: 173

  5. Montano L, Giorgini E, Notarstefano V, Notari T, Ricciardi M, Piscopo M, et al.
    Raman Microspectroscopy evidence of microplastics in human semen

    • Journal: Science of the Total Environment

    • Year: 2023

    • Citations: 120

  6. Ricciardi M, Pironti C, Motta O, Miele Y, Proto A, Montano L.
    Microplastics in the aquatic environment: occurrence, persistence, analysis, and human exposure

    • Journal: Water

    • Year: 2021

    • Citations: 99

  7. Vecoli C, Montano L, Andreassi MG.
    Environmental pollutants: genetic damage and epigenetic changes in male germ cells

    • Journal: Environmental Science and Pollution Research

    • Year: 2016

    • Citations: 85

  8. Lettieri G, D’Agostino G, Mele E, Cardito C, Esposito R, Cimmino A, Montano L, et al.
    Discovery of the involvement in DNA oxidative damage of human sperm nuclear basic proteins of healthy young men living in polluted areas

    • Journal: International Journal of Molecular Sciences

    • Year: 2020

    • Citations: 80

  9. Bergamo P, Volpe MG, Lorenzetti S, Mantovani A, Notari T, Cocca E, Montano L, et al.
    Human semen as an early, sensitive biomarker of highly polluted living environment in healthy men

    • Journal: Reproductive Toxicology

    • Year: 2016

    • Citations: 77

  10. Bosco L, Notari T, Ruvolo G, Roccheri MC, Martino C, Chiappetta R, Montano L, et al.
    Sperm DNA fragmentation: An early and reliable marker of air pollution

  • Journal: Environmental Toxicology and Pharmacology

  • Year: 2018

  • Citations: 67

  1. Lettieri G, Marra F, Moriello C, Prisco M, Notari T, Trifuoggi M, Giarra A, Montano L, et al.
    Molecular alterations in spermatozoa of a family case living in the land of fires—a first look at possible transgenerational effects of pollutants

  • Journal: International Journal of Molecular Sciences

  • Year: 2020

  • Citations: 65

  1. Montano L, Ceretti E, Donato F, Bergamo P, Zani C, Viola GCV, Notari T, et al.
    Effects of a lifestyle change intervention on semen quality in healthy young men living in highly polluted areas in Italy: the FASt randomized controlled trial

  • Journal: European Urology Focus

  • Year: 2022

  • Citations: 64

Shadi Hamoud | Heart diseases | Best Researcher Award

Published on by Global Scholar Awards

Dr. Shadi Hamoud | Heart diseases | Best Researcher Award

Head, research unit at Rambam Health Care Campus, Israel

Dr. Shadi Hamoud is a distinguished physician, researcher, and academic leader specializing in internal medicine, atherosclerosis, and novel cardiovascular treatments. With an MD (cum laude) from Hebrew University and an MPA from the University of Haifa, he serves as a Clinical Senior Lecturer at the Technion-Israel Institute of Technology and Deputy Director of Internal Medicine E at Rambam Medical Center. His research focuses on lipoproteins oxidation, heparanase enzyme roles in kidney and liver diseases, and international clinical trials on cardiovascular medicine, diabetes, and COVID-19 therapies. He has mentored numerous graduate students, contributed extensively to clinical research, and secured competitive research grants. His leadership extends to ethics committees, pharmaceutical consulting, and medical education. Recognized with multiple teaching excellence awards, he actively contributes to professional societies, public health initiatives, and medical advancements, making him a strong candidate for the Best Researcher Award. However, a broader international research collaboration could further enhance his impact.

Professional Profile

Education🎓

Dr. Shadi Hamoud holds an MD degree with cum laude honors from the Hebrew University of Jerusalem, demonstrating his strong academic foundation in medicine. He further pursued an Executive Master of Public Administration (MPA) at the University of Haifa, equipping him with leadership and administrative skills essential for medical research and healthcare management. Throughout his education, he developed a keen interest in internal medicine, atherosclerosis, and cardiovascular diseases, which later became the core of his research. His academic journey also includes specialized training in clinical research, medical ethics, and translational medicine, enhancing his expertise in both theoretical and practical aspects of healthcare. His commitment to continuous learning is evident in his involvement with international research projects and advanced training programs. His diverse educational background not only strengthens his medical proficiency but also enables him to contribute significantly to healthcare policy, medical education, and clinical advancements in cardiovascular and metabolic diseases.

Professional Experience 📝

Dr. Shadi Hamoud is a distinguished physician and researcher specializing in internal medicine, atherosclerosis, and cardiovascular diseases. He has extensive professional experience in clinical practice, medical research, and healthcare administration. As a senior physician, he has worked in leading hospitals, diagnosing and treating complex cardiovascular and metabolic disorders. His expertise extends to translational medicine, bridging the gap between research and patient care. Dr. Hamoud has also been actively involved in clinical trials, contributing to groundbreaking studies on lipid metabolism and atherosclerosis. His leadership roles in medical institutions and research committees reflect his dedication to advancing medical knowledge and improving patient outcomes. Additionally, he has collaborated with international experts, publishing numerous high-impact research papers in peer-reviewed journals. His commitment to medical education is evident through mentoring young researchers and medical students, ensuring the next generation of healthcare professionals is well-equipped to tackle emerging challenges in cardiovascular and metabolic diseases.

Research Interest🔎

Dr. Shadi Hamoud’s research interests focus on cardiovascular diseases, atherosclerosis, and lipid metabolism, with a particular emphasis on the mechanisms underlying cardiovascular risk factors. His work explores the role of cholesterol, inflammation, and metabolic disorders in the development of atherosclerosis, aiming to identify novel therapeutic targets for prevention and treatment. He is also deeply interested in translational medicine, bridging laboratory research with clinical applications to enhance patient care. Dr. Hamoud has contributed significantly to studies on lipid-lowering therapies, biomarkers for cardiovascular risk assessment, and the impact of lifestyle modifications on heart health. His research extends to the intersection of metabolic disorders such as diabetes and obesity with cardiovascular disease, seeking innovative strategies to reduce morbidity and mortality. Through collaborations with international research institutions, he continues to advance scientific understanding in cardiovascular medicine, striving to develop more effective diagnostic tools and personalized treatment approaches for patients with cardiovascular and metabolic diseases.

Award and Honor🏆

Dr. Shadi Hamoud has received numerous awards and honors in recognition of his outstanding contributions to cardiovascular research and medicine. His excellence in scientific innovation and dedication to improving cardiovascular health have earned him prestigious accolades from medical and research institutions worldwide. He has been honored with awards for his groundbreaking work in lipid metabolism and atherosclerosis, highlighting his impact on the field. Additionally, Dr. Hamoud has received research grants and fellowships that have supported his pioneering studies in cardiovascular disease prevention and treatment. His contributions have been recognized through invitations to speak at international conferences, where he has shared his expertise with the global medical community. He has also been acknowledged for his mentorship and leadership in guiding young researchers in the field. Through his achievements, Dr. Hamoud continues to make significant advancements in cardiovascular medicine, earning widespread recognition for his dedication to scientific excellence and patient care.

Research Skill🔬

Dr. Shadi Hamoud possesses exceptional research skills that have significantly advanced the field of cardiovascular medicine. His expertise spans a wide range of methodologies, including molecular biology techniques, lipid metabolism analysis, and advanced imaging technologies for cardiovascular assessment. He is proficient in designing and conducting clinical and laboratory-based studies, utilizing statistical tools to analyze complex datasets, and translating research findings into clinical applications. Dr. Hamoud excels in grant writing and securing research funding, demonstrating his ability to lead high-impact projects. His strong problem-solving skills and critical thinking enable him to address challenging scientific questions effectively. Additionally, his collaborative approach fosters interdisciplinary research, enhancing innovation in cardiovascular disease prevention and treatment. With a keen eye for detail and a commitment to scientific integrity, Dr. Hamoud consistently produces high-quality research that contributes to medical advancements, making him a highly respected figure in the scientific and medical communities.

Conclusion💡

Dr. Shadi Hamoud is a highly suitable candidate for the Best Researcher Award, given his exceptional contributions to cardiovascular research, clinical medicine, and medical education. His extensive mentorship, leadership in international clinical trials, and commitment to translational medicine make him a strong contender. Strengthening his global visibility and publishing more in top-tier journals could further enhance his profile.

Publications Top Noted✍️

  • Title: Potential Nephroprotective Effect of uPA against Ischemia/Reperfusion-Induced Acute Kidney Injury in αMUPA Mice and HEK-293 Cells
    Authors: H.A. Alkhaleq, Heba Abd; I. Hacker, Israel; T. Karram, Tony; A. Kabala, Aviva; Z.A. Abassi, Zaid A.
    Year: 2024

  • Title: Involvement of Heparanase in the Pathogenesis of Acute Pancreatitis: Implication of Novel Therapeutic Approaches
    Authors: D.B. Hamo-Giladi, Dalit B.; A. Fokra, Ahmad; E. Sabo, Edmond; Z.A. Abassi, Zaid A.; I. Khamaysi, Iyad
    Year: 2024

  • Title: Gender-Specific Renoprotective Pathways in αMUPA Transgenic Mice Subjected to Acute Kidney Injury
    Authors: H.A. Alkhaleq, Heba Abd; S. Hamoud, Shadi; I. Hacker, Israel; A. Kabala, Aviva; Z.A. Abassi, Zaid A.
    Year: 2024
    Citations: 2